Ignite Creation Date:
2024-05-06 @ 2:23 AM
Last Modification Date:
2024-10-26 @ 11:17 AM
Study NCT ID:
NCT02032147
Status:
COMPLETED
Last Update Posted:
2014-01-09
First Post:
2013-09-27
Brief Title:
Treatment of Cerebral Radiation Necrosis CRN With Nerve Growth Factor NGF
Sponsor:
Fudan University
Organization:
Fudan University
Study Overview
Official Title:
None
Status:
COMPLETED
Status Verified Date:
2014-01
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Cerebral radiation necrosis CRN is a well-documented late complication of radiation therapy for cancers and may have a devastating effect on the patients quality of life QOL HoweverCRN was once regarded as a progressive and irreversible disease no standard therapy has been suggested for CRN In our clinical practice we have used nerve growth factorNGF to treat CRN and found that GM1 can successfully reverse CRN A case report has been published in Journal of Clinical Oncology JCO in 2011 So we carried out this prospective study to test the efficacy of NGF for CRN
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None